Skip To Content
Precision Medicine for Your Practice: Genomic Testing for the Healthy Individual - CNE is a Course

Precision Medicine for Your Practice: Genomic Testing for the Healthy Individual - CNE

Self-paced
0.5 credits

Enroll

Full course description

About this course

Precision Medicine for Your Practice is a series of short (30 min), online modules covering specific topics in genomics and precision medicine. In this module, Genomic Testing for the Healthy Individual, learn how to elicit patient motivations for genomic testing and to assess if a particular genomic test is a good fit for their concerns. This module will help providers understand the benefits and limitations of different types of genomic tests, know what types of information are available from different types of tests, and increase provider awareness of resources available to help interpret and prioritize results from genomic testing. There are five parts of the module: overview via an animated video; practice cases to facilitate learning-by-doing; "dig deeper" for more in-depth topics; and logistics and additional resources for more detail.

Already enrolled? Access the course here.

CNE Disclosures

Activity Overview:

Precision Medicine for Your Practice: Genomic Testing for the Healthy Individual
Release Date:
January 19, 2018
Expiration Date: September 21, 2020

Objectives
Upon completion of this educational activity, the learner will be able to:

  • Identify patient motivators to enable decisions regarding genomic testing. 
  • Facilitate interpretation of genomic test results from a wide range of test types, including those with lower clinical validity and utility.

Target Audience
This activity is designed to meet the educational needs of practicing nurses and/or advanced practice nurses, physicians and physician assistants.

CNE Approval Statement
The Jackson Laboratory is co-providing this continuing nursing education activity with the American Medical Association and Scripps Translational Science Institute. This continuing nursing education activity was approved by the Northeast Multi-State Division (NE-MSD), an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

Claiming Your Credit
In order to claim credit 1) answer the pre-assessment questions, 2) work through the module content in its entirety, 3) successfully complete the post-assessment answering 2 out of 3 questions correctly and 4) complete the evaluation.    

Nurses are eligible for a maximum of .50 contact hours upon the completion of this activity.

Planning Committee

  • Emily Edelman, MS, CGC, The Jackson Laboratory
  • Therese Ingram, MA, The Jackson Laboratory
  • Sean McConnell, PhD, American Medical Association
  • Laura Nicholson, MD, PhD, Scripps Research Translational Institute
  • Kate Reed, MPH, ScM, CGC, The Jackson Laboratory
  • Linda Steinmark, MS, LGC, The Jackson Laboratory
  • Janet K. Williams, PhD, RN, FAAN, University of Iowa

Abdallah Elias, Jeanette McCarthy, Katherine Johansen Taber, James O’Leary, and Suzanna Schott were involved in planning a previous version of this program.

    Faculty and Authors

    • Emily Edelman, MS, CGC, The Jackson Laboratory
    • Therese Ingram, MA, The Jackson Laboratory
    • Katie Johansen Taber, PhD, Counsyl
    • Laura Nicholson, MD, PhD, Scripps Translational Science Institute
    • Kate Reed, MPH, ScM, CGC, The Jackson Laboratory
    • Linda Steinmark, MS, LGC, The Jackson Laboratory

    Conflict of Interest Disclosure
    Unless otherwise noted, the program planners and faculty do not have a financial interest/arrangement or affiliation with any organizations that could be perceived as a real or apparent conflict of interest in the context of the subject of this course.

    The following disclosures are reported that could be perceived as a real or apparent conflict of interest in the education program:

    Janet K. Williams, PhD, RN, FAAN, stockholder of Pfizer
    Katie Johansen Taber, PhD, Counsyl 

    In her role as a planner, Dr. Williams recused herself from all deliberations relating to content related to the commercial entities with which she has a financial interest and is not responsible for reviewing for bias any related content. All educational material has been peer-reviewed by external reviewers to assess for bias.

    In her role as a content author, Dr. Johansen Taber completed these contributions prior to her employment at Counsyl. This work has also been peer-reviewed by external reviewers to assess for bias.

    References

    American College of Medical Genetics and Genomics. Clinical utility of genetic and genomic services: a position statement. Genet Med. 2015; 17(6):505-507.

    American College of Medical Genetics and Genomics. Direct-to-consumer genetic testing: a revised position statement. Genet Med. 2015; 18(2):207-208.

    American College of Medical Genetics and Genomics. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement. Genet Med. 2016; 19(2):249-255.

    Baptista NM, Christensen KD, Carere DA, Broadley SA, Roberts JS, Green RC. Adopting genetics: motivations and outcomes of personal genomic testing in adult adoptees. Genet Med. 2016; 18(9):924-932.

    Bunnik EM, Janssens ACJW, Schermer MHN. Personal utility in genomic testing: is there such a thing? J Med Ethics. 2015; 41(4):322-326.

    Garrison NA, Non AL. Direct-to-Consumer Genomics Companies Should Provide Guidance to Their Customers on (Not) Sharing Personal Genomic Information. The American Journal of Bioethics. 2014; 14(11):55-57.

    Kirkpatrick BE, Rashkin MD. Ancestry Testing and the Practice of Genetic Counseling. J Genet Counsel. 2016; 26(1):6-20.

    Kozlovskaia M, Vlahovich N, Ashton KJ, Hughes DC. Biomedical Risk Factors of Achilles Tendinopathy in Physically Active People: a Systematic Review. Sports Med - Open. 2017; 3(1):20-33.

    Linderman M, Nielsen D, Green R. Personal Genome Sequencing in Ostensibly Healthy Individuals and the PeopleSeq Consortium. 2016; 6(2):14-29.

    Lindor NM, Thibodeau SN, Burke W. Whole-Genome Sequencing in Healthy People. Mayo Clinic Proceedings. 2017; 92(1):159-172.

    Lu M, Lewis CM, Traylor M. Pharmacogenetic testing through the direct-to-consumer genetic testing company 23andMe. BMC Med Genomics. 2017; 10(1):47-54.

    Lupo PJ, Robinson JO, Diamond PM et al. Patients’ perceived utility of whole-genome sequencing for their healthcare: findings from the MedSeq project. Personalized Medicine. 2016; 13(1):13-20.

    Niemiec E, Howard HC. Ethical issues in consumer genome sequencing: Use of consumers' samples and data. Applied & Translational Genomics. 2016; 8:23-30.

    Ostergren JE, Gornick MC, Carere DA et al. How Well Do Customers of Direct-to-Consumer Personal Genomic Testing Services Comprehend Genetic Test Results? Findings from the Impact of Personal Genomics Study. Public Health Genomics. 2015; 18(4):216-224.

    Topol E. Individualized Medicine from Pre-womb to Tomb. 2014; 157(1):241-253.

    Vassy JL, Christensen KD, Schonman EF et al. The Impact of Whole-Genome Sequencing on the Primary Care and Outcomes of Healthy Adult Patients. Ann Intern Med. 2017; 167(3):159-70.

    Wang L, McLeod HL, Weinshilboum RM. Genomics and Drug Response. N Engl J Med. 2011; 364(12):1144-1153.

    Wasson K, Sanders TN, Hogan NS, Cherny S, Helzlsouer KJ. Primary care patients’ views and decisions about, experience of and reactions to direct-to-consumer genetic testing: a longitudinal study. J Community Genet. 2013; 4(4):495-505.

    Hardware/software Requirements

    Audio speakers or headphones
    Screen resolution of 800X600 or higher
    Adobe Reader 5.0 or higher 

    Review the basic computer specifications and supported browsers.

    Should you have questions regarding the content of the activity, please email Kate Reed or call 207.288.6971.
    Should you have technical questions, please email 
    Therese Ingram.

    Disclaimer 
    All information in Precision Medicine for Your Practice is provided for educational purposes only. This information is not a substitute for clinical guidance or the consultation of a medical professional. Always seek the advice of a qualified health professional with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read in Precision Medicine for Your Practice. Reliance on any information in Precision Medicine for Your Practice is solely at your own risk. The Jackson Laboratory does not endorse or recommend any specific procedures, tests, products, services, health professionals or other information that may be found in Precision Medicine for Your Practice.

    Sign up for this course today!

    Enroll